ATE405669T1 - Remodellierung von glycoproteinen unter verwendung von endoglycanasen - Google Patents

Remodellierung von glycoproteinen unter verwendung von endoglycanasen

Info

Publication number
ATE405669T1
ATE405669T1 AT02786845T AT02786845T ATE405669T1 AT E405669 T1 ATE405669 T1 AT E405669T1 AT 02786845 T AT02786845 T AT 02786845T AT 02786845 T AT02786845 T AT 02786845T AT E405669 T1 ATE405669 T1 AT E405669T1
Authority
AT
Austria
Prior art keywords
glycoproteins
endoglycanases
remodeling
provides methods
recombinantly produced
Prior art date
Application number
AT02786845T
Other languages
English (en)
Inventor
Shawn Defrees
Karl Johnson
Original Assignee
Neose Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neose Technologies Inc filed Critical Neose Technologies Inc
Application granted granted Critical
Publication of ATE405669T1 publication Critical patent/ATE405669T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/006—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length of peptides containing derivatised side chain amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Analytical Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT02786845T 2001-11-28 2002-11-27 Remodellierung von glycoproteinen unter verwendung von endoglycanasen ATE405669T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33430101P 2001-11-28 2001-11-28

Publications (1)

Publication Number Publication Date
ATE405669T1 true ATE405669T1 (de) 2008-09-15

Family

ID=23306575

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02786845T ATE405669T1 (de) 2001-11-28 2002-11-27 Remodellierung von glycoproteinen unter verwendung von endoglycanasen

Country Status (7)

Country Link
EP (1) EP1461445B1 (de)
JP (1) JP2005535280A (de)
AT (1) ATE405669T1 (de)
AU (1) AU2002351199A1 (de)
CA (1) CA2468295C (de)
DE (1) DE60228492D1 (de)
WO (1) WO2003046150A2 (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7173003B2 (en) 2001-10-10 2007-02-06 Neose Technologies, Inc. Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
US7214660B2 (en) 2001-10-10 2007-05-08 Neose Technologies, Inc. Erythropoietin: remodeling and glycoconjugation of erythropoietin
CA2519092C (en) 2003-03-14 2014-08-05 Neose Technologies, Inc. Branched water-soluble polymers and their conjugates
EP1615945B1 (de) 2003-04-09 2011-09-28 BioGeneriX AG Glycopegylierungsverfahren und durch die verfahren hergestellte proteine/peptide
US9005625B2 (en) 2003-07-25 2015-04-14 Novo Nordisk A/S Antibody toxin conjugates
US8633157B2 (en) 2003-11-24 2014-01-21 Novo Nordisk A/S Glycopegylated erythropoietin
US20080305992A1 (en) 2003-11-24 2008-12-11 Neose Technologies, Inc. Glycopegylated erythropoietin
US7956032B2 (en) 2003-12-03 2011-06-07 Novo Nordisk A/S Glycopegylated granulocyte colony stimulating factor
CN101072789B (zh) 2004-01-08 2013-05-15 生物种属学股份公司 肽的o-连接的糖基化
EP1745141B2 (de) 2004-05-04 2019-09-25 Novo Nordisk Health Care AG O-verknüpfte glykoformen von faktor vii und verfahren zu deren herstellung
US20080300173A1 (en) 2004-07-13 2008-12-04 Defrees Shawn Branched Peg Remodeling and Glycosylation of Glucagon-Like Peptides-1 [Glp-1]
WO2006031811A2 (en) 2004-09-10 2006-03-23 Neose Technologies, Inc. Glycopegylated interferon alpha
WO2006035057A1 (en) * 2004-09-29 2006-04-06 Novo Nordisk Health Care Ag Modified proteins
HUE026826T2 (en) 2004-10-29 2016-07-28 Ratiopharm Gmbh Modeling and glycopegylation of fibroblast growth factor (FGF)
ES2449195T3 (es) 2005-01-10 2014-03-18 Ratiopharm Gmbh Factor estimulante de colonias de granulocitos glicopegilado
WO2006088017A1 (ja) * 2005-02-16 2006-08-24 National University Corporation Hokkaido University ４位ハロゲン化ガラクトース含有糖鎖及びその応用
WO2006121569A2 (en) 2005-04-08 2006-11-16 Neose Technologies, Inc. Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
EP1888098A2 (de) 2005-05-25 2008-02-20 Neose Technologies, Inc. Glykopegylierte erythropoetin-formulierungen
US20070105755A1 (en) 2005-10-26 2007-05-10 Neose Technologies, Inc. One pot desialylation and glycopegylation of therapeutic peptides
US20090048440A1 (en) 2005-11-03 2009-02-19 Neose Technologies, Inc. Nucleotide Sugar Purification Using Membranes
DK1991273T4 (da) 2006-02-10 2022-02-07 Life Technologies Corp Mærkning og påvisning af post-translationelt modificerede proteiner
ES2516694T3 (es) 2006-07-21 2014-10-31 Ratiopharm Gmbh Glicosilación de péptidos a través de secuencias de glicosilación con unión en O
US8969532B2 (en) 2006-10-03 2015-03-03 Novo Nordisk A/S Methods for the purification of polypeptide conjugates comprising polyalkylene oxide using hydrophobic interaction chromatography
PT2101821E (pt) 2006-12-15 2014-10-03 Baxter Int Fator conjugado viia-ácido (poli)siálico com prolongamento do tempo de meia vida in vivo
PL2144923T3 (pl) 2007-04-03 2013-12-31 Biogenerix Ag Sposoby leczenia z użyciem glikopegilowanego G-CSF
US9493499B2 (en) 2007-06-12 2016-11-15 Novo Nordisk A/S Process for the production of purified cytidinemonophosphate-sialic acid-polyalkylene oxide (CMP-SA-PEG) as modified nucleotide sugars via anion exchange chromatography
US8207112B2 (en) 2007-08-29 2012-06-26 Biogenerix Ag Liquid formulation of G-CSF conjugate
WO2009108806A1 (en) 2008-02-27 2009-09-03 Novo Nordisk A/S Conjugated factor viii molecules
CA2733362C (en) 2008-08-08 2016-10-18 Universiteit Gent Cells producing glycoproteins having altered glycosylation patterns and methods and use thereof
EP4212541A1 (de) * 2008-12-16 2023-07-19 Genzyme Corporation Oligosaccharid-protein-konjugate und zwischenprodukte davon
CN107375919B (zh) 2009-03-27 2022-07-29 台湾地区“中央研究院” 抗病毒免疫的方法和组合物
RU2744370C2 (ru) 2009-07-27 2021-03-05 Баксалта Инкорпорейтед Конъюгаты белков свертывания крови
EP2459224B1 (de) 2009-07-27 2016-06-01 Baxalta GmbH Koagulationsproteinkonjugate
CA2769244A1 (en) 2009-07-27 2011-02-03 Lipoxen Technologies Limited Glycopolysialylation of non-blood coagulation proteins
US8642737B2 (en) 2010-07-26 2014-02-04 Baxter International Inc. Nucleophilic catalysts for oxime linkage
US8809501B2 (en) 2009-07-27 2014-08-19 Baxter International Inc. Nucleophilic catalysts for oxime linkage
TWI537385B (zh) * 2010-11-04 2016-06-11 中央研究院 產生具簡單醣基化之表面蛋白質之病毒顆粒的方法
HUE049352T2 (hu) 2010-12-22 2020-09-28 Baxalta GmbH Anyagok és módszerek egy vízoldható zsírsavszármazéknak egy fehérjéhez való konjugálására
US10851174B2 (en) 2011-03-03 2020-12-01 University Of Maryland, Baltimore Core fucosylated glycopeptides and glycoproteins: chemoenzymatic synthesis and uses thereof
IN2014DN06806A (de) 2012-02-10 2015-05-22 Univ Maryland
US11293012B2 (en) 2015-07-09 2022-04-05 Vib Vzw Cells producing glycoproteins having altered N- and O-glycosylation patterns and methods and use thereof
JP6852939B2 (ja) 2017-09-04 2021-03-31 ８９バイオ リミテッド８９Ｂｉｏ Ｌｔｄ． 変異体ｆｇｆ−２１ペプチドコンジュゲート及びその使用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU597574B2 (en) 1986-03-07 1990-06-07 Massachusetts Institute Of Technology Method for enhancing glycoprotein stability
US6030815A (en) 1995-04-11 2000-02-29 Neose Technologies, Inc. Enzymatic synthesis of oligosaccharides
US5922577A (en) 1995-04-11 1999-07-13 Cytel Corporation Enzymatic synthesis of glycosidic linkages
US5728554A (en) 1995-04-11 1998-03-17 Cytel Corporation Enzymatic synthesis of glycosidic linkages
US5876980A (en) 1995-04-11 1999-03-02 Cytel Corporation Enzymatic synthesis of oligosaccharides
ATE263841T1 (de) 1997-01-16 2004-04-15 Neose Technologies Inc Praktische in vitro sialylierung von rekombinanten glykpproteinen
AU2001263149A1 (en) * 2000-05-12 2001-11-26 Neose Technologies, Inc. In vitro fucosylation recombinant glycopeptides

Also Published As

Publication number Publication date
AU2002351199A1 (en) 2003-06-10
CA2468295C (en) 2010-08-03
DE60228492D1 (de) 2008-10-02
WO2003046150A3 (en) 2003-11-27
EP1461445A2 (de) 2004-09-29
EP1461445B1 (de) 2008-08-20
CA2468295A1 (en) 2003-06-05
JP2005535280A (ja) 2005-11-24
WO2003046150A2 (en) 2003-06-05
EP1461445A4 (de) 2005-08-17

Similar Documents

Publication Publication Date Title
ATE405669T1 (de) Remodellierung von glycoproteinen unter verwendung von endoglycanasen
WO2003045980A3 (en) Glycopeptide remodeling using amidases
MXPA02011016A (es) Glicopeptidos recombinantes de glucolisacion in vitro.
DE69823046D1 (de) Praktische in vitro sialylierung von rekombinanten glykpproteinen
EG23427A (en) Cultivated agarwood.
DE69635948D1 (de) Methoden zur modifikation von kohlenhydratanteilen
IL149459A0 (en) Recombinant gelatins
ATE557544T1 (de) Adaptive filterung in abhängigkeit von der blockkantenstärke
ATE392430T1 (de) Verfahren zur herstellung von dipeptiden
BRPI0510295A (pt) preparação de uma glicoproteìna, e, método para produzir a mesma
DE60124730D1 (de) Neue methoden unter verwendung von cholinesteraseinhibitoren
BR0206429A (pt) Composição alvejante para a lavagem de roupa, método de branqueamento de um substrato, e, ligando
DE60316726D1 (de) Verfahren zur herstellung eines pressfilzes und pressfilz in form einer geschlossenen schleife
DE60336956D1 (de) Laserstrahlmaschine
DE69915310D1 (de) Methoden zur behandlung der salzabhängigen hypertonie
DK1078063T3 (da) BASB029-polynukleotider og -polypeptider fra Neisseria meningitidis
DE60033576D1 (de) Methoden zum screening knochenmorphogenetishemimetika
ATE554426T1 (de) Verfahren zur ermöglichung der übertragung von im wesentlichen gleichen energiemengen
ATE360371T1 (de) Konfekt mit rauhstruktur zur behandlung von halitose
DE60212635D1 (de) Imidsalze als emulgatoren für die polymerisation von fluorolefinen
ATE323677T1 (de) Verfahren zur herstellung von 4-amino-2,5- bisheterocyclylchinazolinen
DK1112366T3 (da) Polynucleotider og polypeptider BASB033 fra Neisseria Meningitidis samt deres anvendelser
ATE470442T1 (de) Verwendung von gamma-tocotrienol als diuretika
DE50211365D1 (de) Substituierte 1-phenethylpiperidinverbindungen, die unter anderem als analgetika verwendung finden
ATE259256T1 (de) Düse zur verdünnung von phosphorwasserstoff

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties